GPT Healthcare Ltd Q1 FY26 – ROCE 27.2%, Dividend Yield 1.64%, Market Cap ₹1,228 Cr – Can Tier-II Hospitals Punch Above Their Weight?

1. At a Glance

GPT Healthcare Ltd, operating under the ILS Hospitals brand, is Eastern India’s specialist in running mid-sized multi-specialty hospitals. With 719 beds across 5 facilities, 91 full-time consultants, and 570 visiting doctors, it’s not Apollo-sized, but it’s no mohalla clinic either. Current market cap sits at ₹1,228 Cr, stock price ₹150 (a 22% discount from its high of ₹192). It trades at a P/E of 25.8—a relative bargain when peers like Apollo and Max are demanding 70–90x. Return metrics shine with ROE of 21.3% and ROCE of 27.2%, putting many bigger names to shame. But here’s the catch: Q1 PAT fell 23% YoY, reminding us that hospitals may save lives, but can’t always save profits.

2. Introduction

If Apollo Hospitals is the five-star Taj Mahal Palace of Indian healthcare, GPT Healthcare is your friendly yet surprisingly efficient Park Street business hotel. Smaller, cheaper, but delivering ROI that would make Apollo’s CFO raise an eyebrow.

Operating primarily in Tier I and Tier II cities of Eastern India, GPT is targeting a sweet spot—middle-class families who can’t afford Apollo’s ₹3 lakh knee replacement but also don’t trust “Dr. Gupta’s Nursing Home.” With ARPOB (Average Revenue Per Occupied Bed) at ₹37,180 and ALOS (Average Length of Stay) of 3.5 days, GPT runs a business model that’s neither “cheap and cheerful” nor “luxury and loot.”

But healthcare investing is like an Indian joint family: glamorous cousins (Apollo, Max) hog the limelight, while smaller players quietly handle the house budget. GPT’s story is about whether small can stay beautiful—or get crushed by the giants.

3. Business Model – WTF Do They Even Do?

GPT Healthcare runs hospitals, but let’s add some masala:

• Salt Lake (Kolkata) – 85 beds, ₹71 Cr revenue, specializes in bariatric surgery (read: “fat-to-fit packages”). Bed occupancy ~58%.
• Agartala (Tripura) – 205 beds, ₹118 Cr revenue, NABH-accredited, launching Cancer Care. Occupancy ~46% (Tripura patients prefer home remedies until it’s serious).
• Dum Dum (Kolkata) – 155 beds, star performer, ₹162 Cr revenue, occupancy 69%. Licensed for renal transplants, with 3D imaging tech. Basically, their Kohli of hospitals.
• Howrah – 116 beds, ₹57 Cr revenue, only 41% occupancy. But hey, they do robotic knee replacements. Maybe AI surgeons will be the USP.
• Raipur – 158 beds, brand new, ₹74 Cr investment (~₹4.7 Mn per bed, cheaper than Apollo’s ₹8–10 Mn).

Core model: mid-sized, multi-specialty hospitals in under-served cities. The twist? They run asset-light, often leasing instead of buying land/buildings. In an industry where capex is a black hole, GPT is trying to play it like a Marwari businessman—“paisa bachao, rotation karo.”

4. Financials Overview

Commentary: Revenue is healthy, but EBITDA margin fell to 16% vs 22% YoY. PAT chopped in half. Looks like new hospitals are eating up profits faster than canteen samosas.

Question for readers: Would you pay Apollo-like